Mylan Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Mylan careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

FOR US, IT\'S A MISSION At Mylan, we mean it when we say we work every day to provide access to high quality medicines to the world's 7 billion people. If you are unconventional, relentless and passionate. If you believe in doing what's ...
Posted: July 19, 2018, 2:17 pm
FOR US, IT\'S A MISSION At Mylan, we mean it when we say we work every day to provide access to high quality medicines to the world's 7 billion people. If you are unconventional, relentless and passionate. If you believe in doing what's right, not...
Posted: July 19, 2018, 10:44 am
For Us, It\'s A Mission At Mylan, we mean it when we say we work every day to provide access to high quality medicines to the world's 7 billion people. If you are unconventional, relentless and passionate. If you believe in doing what's right, not...
Posted: July 17, 2018, 10:46 am
FOR US, ITS A MISSION At Mylan, we mean it when we say we work every day to provide access to high quality medicines to the worlds 7 billion people. If you are unconventional, relentless and passionate. If you believe in doing wha...
Posted: July 13, 2018, 12:41 pm
For Us, It\'s A Mission At Mylan, we mean it when we say we work every day to provide access to high quality medicines to the world's 7 billion people. If you are unconventional, relentless and passionate. If you believe in doing what's right...
Posted: July 3, 2018, 8:51 pm

Viewing page 1 of 5|Next Page

  Newsfeed | Subscribe  

(Reuters) - AbbVie Inc said on Tuesday it signed a U.S. licensing deal with Mylan NV for its proposed biosimilar to AbbVie's blockbuster drug Humira, in a move that will give it more near-term control ...
Posted: July 19, 2018, 1:45 am
AbbVie, Inc. ABBV has signed a non-exclusive licensing deal with Mylan MYL regarding the latter’s proposed biosimilar version of AbbVie’s blockbuster arthritis drug, Humira, in the United States. Per ...
Posted: July 18, 2018, 7:48 am
Investors in Mylan NV (Symbol: MYL) saw new options begin trading today, for the August 31st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MYL options chain f...
Posted: July 12, 2018, 8:04 am
has approved Mylan’s trademarked Fulphila, which will be offered as an alternative to the name-brand Neulasta (pegfilgrastim). An Amgen Inc. product, Neulasta is injected to stimulate the growth of he...
Posted: July 8, 2018, 12:00 am
PITTSBURGH, Jan. 31 -- Mylan Laboratories Inc. (NYSE:MYL) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval for Mylan Technologies' Supplemental Abbreviated N...
Posted: June 27, 2018, 5:00 pm

Viewing page 1 of 2|Next Page